EC
GDRX icon

EntryPoint Capital’s GoodRx Holdings GDRX Stock Holding History

EntryPoint Capital’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,425
Closed -$133K – 735
2025
Q3 		$133K Sell
31,425
-46,382
-60% -$204K 0.05% 604
2025
Q2 		$387K Buy
77,807
+18,887
+32% +$82K 0.19% 177
2025
Q1 		$260K Buy
58,920
+46,826
+387% +$220K 0.12% 407
2024
Q4 		$56.2K Buy
+12,094
New +$66.5K 0.02% 687
2024
Q2 		– Sell
-18,538
Closed -$132K – 1162
2024
Q1 		$132K Buy
18,538
+11,548
+165% +$76.4K 0.12% 284
2023
Q4 		$46.8K Buy
+6,990
New +$39.4K 0.04% 754

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

EntryPoint Capital's GDRX Position: Q4 2025 in Review

EntryPoint Capital sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 31,425 shares — an estimated $133K sold.

EntryPoint Capital first reported a position in GDRX in Q4 2023 and held it in 6 quarters. The position peaked at $387K in Q2 2025. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

  • EntryPoint Capital reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
  • EntryPoint Capital sold 31,425 GoodRx Holdings shares in Q4 2025, an estimated $133K.
  • EntryPoint Capital first reported a position in GoodRx Holdings in Q4 2023 and held it in 6 quarters.
  • EntryPoint Capital's GoodRx Holdings position peaked at $387K in Q2 2025.
  • 183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.